Stroke severity and outcomes for octogenarians receiving statins

Archives of Gerontology and Geriatrics

Volumn 57, Issue 3, 2013, Pages 377-382

  Phipps, Michael S ^a,b   Zeevi, Neer ^c   Staff, Ilene ^a   Fortunato, Gil ^a   Kuchel, George A ^b   McCullough, Louise D ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c Lawrence and Memorial Hospital   (United States)

Author keywords

3 Hydroxy 3 methylgutaryl coenzyne A reductase inhibitor; Elderly; Ischemic stroke; Statin; Stroke severity

Indexed keywords

ANTITHROMBOCYTIC AGENT; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; AGING; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR;

3-HYDROXY-3-METHYLGUTARYL-COENZYNE A REDUCTASE INHIBITOR; ELDERLY; ISCHEMIC STROKE; STATIN; STROKE SEVERITY;

AGE FACTORS; AGED, 80 AND OVER; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; PATIENT OUTCOME ASSESSMENT; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84881668412     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2013.05.007     Document Type: Article

References (36)

1. Aboa-Eboule C., Binquet C., Jacquin A., Hervieu M., Bonithon-Kopp C., Durier J., et al. Effect of previous statin therapy on severity and outcome in ischemic stroke patients: A population-based study. Journal of Neurology 2012 June.
2. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
3. Alhusban A., Fagan S.C. Secondary prevention of stroke in the elderly: A review of the evidence. The American Journal of Geriatric Pharmacotherapy 2011, 9:143-152.
4. Bauer K.A., Weiss L.M., Sparrow D., Vokonas P.S., Rosenberg R.D. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. Journal of Clinical Investigation 1987, 80:1527-1534.
5. Bushnell C.D., Griffin J., Newby L.K., Goldstein L.B., Mahaffey K.W., Graffagnino C.A., et al. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 2006, 37:1427-1431. Epub 2006 April 1427.
6. Cimino M., Gelosa P., Gianella A., Nobili E., Tremoli E., Sironi L. Statins: Multiple mechanisms of action in the ischemic brain. Neuroscientist 2007, 13:208-213.
7. Di Carlo A., Lamassa M., Pracucci G., Basile A.M., Trefoloni G., Vanni P., et al. Stroke in the very old: Clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group. Stroke 1999, 30:2313-2319.
8. Elkind M.S., Flint A.C., Sciacca R.R., Sacco R.L. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005, 65:253-258.
9. Fuentes B., Martinez-Sanchez P., Diez-Tejedor E. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovascular Diseases 2009, 27(Suppl. 1):126-133. Epub 2009 April 2003.
10. Goldstein L.B. Low LDL cholesterol, statins, and brain hemorrhage: Should we worry?. Neurology 2007, 68:719-720.
11. Goldstein L.B., Amarenco P., Zivin J., Messig M., Altafullah I., Callahan A., et al. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2009, 40:3526-3531.
12. Greenberg S.M., Vonsattel J.P. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 1997, 28:1418-1422.
13. Greisenegger S., Mullner M., Tentschert S., Lang W., Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. Journal of Neurological Sciences 2004, 221:5-10.
14. Hackam D.G., Woodward M., Newby L.K., Bhatt D.L., Shao M., Smith E.E., et al. Statins and intracerebral hemorrhage: Collaborative systematic review and meta-analysis. Circulation 2011, 124:2233-2242.
15. Hey-Hadavi J.H., Kuntze E., Luo D., Silverman P., Pittman D., Lepetri B. Tolerability of atorvastatin in a population aged >or =65 years: A retrospective pooled analysis of results from fifty randomized clinical trials. The American Journal of Geriatric Pharmacotherapy 2006, 4:112-122.
16. Hjalmarsson C., Bokemark L., Manhem K., Mehlig K., Andersson B. The effect of statins on acute and long-term outcome after ischemic stroke in the elderly. The American Journal of Geriatric Pharmacotherapy 2012, 10:313-322. doi:310.1016/j.amjopharm.2012.1009.1001.
17. Jonsson N., Asplund K. Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke 2001, 32:1112-1115.
18. Kostis W.J., Cheng J.Q., Dobrzynski J.M., Cabrera J., Kostis J.B. Meta-analysis of statin effects in women versus men. Journal of the American College of Cardiology 2012, 59:572-582.
19. Lakhan S.E., Bagchi S., Hofer M. Statins and clinical outcome of acute ischemic stroke: A systematic review. International Archives of Medicine 2010, 3:22.
20. Lyden P., Lu M., Jackson C., Marler J., Kothari R., Brott T., et al. Underlying structure of the National Institutes of Health Stroke Scale: Results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke 1999, 30:2347-2354.
21. Lynch J.E., Henderson N.R., Ramage L., McMurdo M.E., Witham M.D. Association between statin medication use and improved outcomes during inpatient rehabilitation in older people. Age and Ageing 2012, 41:260-262. Epub 2011 December 2018.
22. Marti-F‡bregas J., Gomis M., Arboix A., Aleu A., Pagonabarraga J., Belvis R., et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004, 35:1117-1121.
23. Martinez-Sanchez P., Rivera-Ordonez C., Fuentes B., Ortega-Casarrubios M.A., Idrovo L., Diez-Tejedor E. The beneficial effect of statins treatment by stroke subtype. European Journal of Neurology 2009, 16:127-133.
24. Meier N., Nedeltchev K., Brekenfeld C., Galimanis A., Fischer U., Findling O., et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke 2009, 40:1729-1737. Epub 2009 March 1725.
25. Moonis M., Kane K., Schwiderski U., Sandage B.W., Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005, 36:1298-1300. Epub 2005 May 1295.
26. Ni Chroinin D., Asplund K., Asberg S., Callaly E., Cuadrado-Godia E., Diez-Tejedor E., et al. Statin therapy and outcome after ischemic stroke: Systematic review and meta-analysis of observational studies and randomized trials. Stroke 2013, 44:448-456.
27. Olindo S., Cabre P., Deschamps R., Chatot-Henry C., Rene-Corail P., Fournerie P., et al. Acute stroke in the very elderly: Epidemiological features, stroke subtypes, management, and outcome in Martinique, French West Indies. Stroke 2003, 34:1593-1597.
28. Persky R.W., Turtzo L.C., McCullough L.D. Stroke in women: Disparities and outcomes. Current Cardiology Reports 2010, 12:6-13.
29. Reeves M.J., Gargano J.W., Luo Z., Mullard A.J., Jacobs B.S., Majid A. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 2008, 39:1779-1785.
30. Shah S., Vanclay F., Cooper B. Improving the sensitivity of the Barthel index for stroke rehabilitation. Journal of Clinical Epidemiology 1989, 42:703-709.
31. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L.E.M., Buckley B.M., Cobbe S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. The Lancet 2002, 360:1623-1630.
32. Turtzo L.C., McCullough L.D. Sex differences in stroke. Cerebrovascular Diseases 2008, 26:462-474.
33. Wolfe C.D.A., Crichton S.L., Heuschmann P.U., McKevitt C.J., Toschke A.M., Grieve A.P., et al. Estimates of outcomes up to ten years after stroke: Analysis from the prospective South London Stroke Register. PLoS Medicine 2011, 8.
34. Yu A.Y.X., Keezer M.R., Zhu B., Wolfson C., Cote R. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes. Cerebrovascular Diseases 2009, 27:398-402.
35. Zeevi N., Chhabra J., Silverman I.E., Lee N.S., McCullough L.D. Acute stroke management in the elderly. Cerebrovascular Diseases 2007, 23:304-308.
36. Zeevi N., Pachter J., McCullough L.D., Wolfson L., Kuchel G.A. The blood-brain barrier: Geriatric relevance of a critical brain-body interface. Journal of the American Geriatrics Society 2010, 58:1749-1757.